BioXcel Therapeutics (BTAI) Treasury Shares (2022 - 2026)

BioXcel Therapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $1072.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 98.21% year-over-year to $1072.0; the TTM figure through Mar 2026 stood at $1072.0 (down 98.21% YoY), while the FY2025 annual figure was $107000.0, down 90.82% from the prior year.
• Treasury Shares was $1072.0 for Q1 2026 at BioXcel Therapeutics, down from $107000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.2 million in Q4 2024 to a low of $137.0 in Q3 2025.
• Historically, Treasury Shares has averaged $127144.8 across 5 years, with a median of $32500.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares soared 93932.26% in 2024, then sank 99.9% in 2025.
• A 5-year view of Treasury Shares shows it stood at $119000.0 in 2022, then tumbled by 98.96% to $1240.0 in 2023, then jumped by 93932.26% to $1.2 million in 2024, then tumbled by 90.82% to $107000.0 in 2025, then tumbled by 99.0% to $1072.0 in 2026.
• The last three Treasury Shares figures came in at $1072.0 (Q1 2026), $107000.0 (Q4 2025), and $137.0 (Q3 2025), per Business Quant data.